|Bid||17.00 x 1800|
|Ask||17.75 x 1100|
|Day's Range||17.20 - 18.09|
|52 Week Range||4.63 - 26.35|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 7, 2018 - Nov 12, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||22.00|
BioLife Solutions (BLFS) develops, manufactures, and commercializes cell and tissue hypothermic storage and cryopreservation freeze media. BioLife Solutions generated revenues of $5.18 million in the second quarter compared to $2.56 million in the second quarter of 2017. For fiscal 2018 and fiscal 2019, BioLife is expected to generate revenues of $19.89 million and $28.36 million, respectively, compared to $11.02 million in fiscal 2017.
BioLife Solutions (BLFS) generated a net income of $1.05 million in the second quarter compared to a net loss of $768,212 in the second quarter of 2017. That translates to net income per share of $0.05 in the second quarter. Its net loss per share was $0.06 in the second quarter of 2017.
Gene therapy involves repairing or replacing disease-causing genes. Investor interest in gene therapy stocks has remained buoyant throughout 2018. According to Allied Market Research, the gene therapy market is expected to grow at a 33.3% CAGR (compound annual growth rate) to $4.4 billion by 2023.
BOTHELL, Wash., Sept. 5, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS) ("BioLife"), the leading supplier of proprietary biopreservation media products for cell and gene therapies, today announced that it has increased its ownership of SAVSU Technologies from approximately 31% to 44% with a $5 million investment. SAVSU will use the investment to scale up its operations and inventory to support increased demand for its evo® Dry Vapor Shippers and other precision temperature controlled shipping containers for cell and gene therapies. The 18-month purchase option provides BioLife, at its sole discretion, with the right to acquire the 56% of SAVSU not already owned, for the greater of 1,000,000 shares of BioLife common stock, or approximately $23 million of BioLife common stock, calculated on the day of exercise. If BioLife exercises the purchase option in the future, 75% of the shares would be issued at closing, with the remaining 25% issued upon the achievement of specific revenue milestones.
Strong economic fundamentals of the United States suggest that the recent volatility may be transitory and that markets will continue their uptrend.
NEW YORK, Aug. 24, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Seres ...
BOTHELL, Wash. , Aug. 22, 2018 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife"), the leading supplier of proprietary biopreservation media products for cell and gene therapies ...
Revenue increases 102% to $5.2 million . Net income of $1.0 million achieved Full-year 2018 GAAP net income expected Conference call and webcast begin at 10:00 a.m. Eastern time today BOTHELL, Wash. , ...
M&A Activities to Focus on Cell and Gene Manufacturing Tools BOTHELL, Wash. , Aug. 9, 2018 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary ...
NEW YORK, NY / ACCESSWIRE / August 9, 2018 / BioLife Solutions, Inc. (NASDAQ: BLFS ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 9, 2018 at 10:00 AM Eastern ...
BOTHELL, Wash. , Aug. 6, 2018 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade biopreservation media, ("BioLife" ...
BOTHELL, Wash. , Aug. 2, 2018 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade biopreservation media, ("BioLife" ...
6 Additional Pending Patent Applications Submitted for evo Smart Shippers, Liquid Nitrogen Dry Vapor Shippers and Cold Chain SaaS Application ALBUQUERQUE, N.M., July 31, 2018 /PRNewswire/ -- SAVSU Technologies ...
Investors aim to invest in companies that have high profitability level irrespective of the current market scenario. In this respect, profitability analysis can be used to detect a profitable company from a loss-making one. Here, we have used the concept of accounting ratios to evaluate a company’s profitability.